Tumor recurrence after complete resection for non-small cell lung cancer.
about
Update in lung cancer and mesothelioma 2012Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasisImpact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.Local recurrence following lung cancer surgery: incidence, risk factors, and outcomesDifferences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.PICT1 expression is a poor prognostic factor in non-small cell lung cancer.Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung CancerTransbronchial and transesophageal fine-needle aspiration using a single ultrasound bronchoscope in the diagnosis of locoregional recurrence of surgically-treated lung cancerAberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signallingCost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerLung cancer prognosis before and after recurrence in a population-based settingCompletely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survivalPhotodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future DirectionsRisk factors of postoperative recurrences in patients with clinical stage I NSCLC.Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer.Stemness and plasticity of lung cancer cells: paving the road for better therapy.Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery.Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways.Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer.Stage II-IV lung cancer cases with lymphovascular invasion relapse within 2 years after surgery.EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma.Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer.Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer.Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?"
P2860
Q24619675-59398798-8962-4286-AEA8-EA6E590E33DBQ27311384-A6DE8DA9-ACDB-404F-8DDB-3B392932C35EQ30275205-7C9C868F-EE7E-4C26-8DE6-0409B18BC576Q30411297-92852DDE-FDF4-4109-A3B7-B75AF0854DECQ34635787-A2BA1433-1006-4545-B7C0-B25548D44E7FQ34781290-8954DAF1-B535-412C-BF7F-FAE50A6D7235Q35822727-A9250B7E-F530-4474-9DCF-87393E66A9D7Q36292310-9D1C7EC8-B576-406D-B735-6F512AF8CC01Q36341597-B7F8661A-BBC3-4668-805B-B33B90029297Q36558386-B17F5648-DC6E-4A17-82D6-725B38200A63Q36817059-A604B0C3-6737-43F9-8131-21643D8C29DCQ37171930-A946F95E-897F-4968-85B1-2C18332C688BQ37241539-661C1FEF-3BE5-41A2-B11C-458C3EB00AA8Q37493587-F6343FDE-4D55-4F46-A95A-914A2C51195FQ37643548-4D14B886-9F6A-4AEC-A972-567A06633826Q38229007-13F0CA10-58C4-4A72-8DD9-A94E011E2392Q38667951-840A0E66-940C-41B7-BCB2-EBEECF9721CFQ38785873-817A48B3-5F4D-440B-AD05-C2DAABE18FB7Q38902680-692F4301-93AB-4235-BAEF-FD20E1E00143Q42747196-137F7DB7-43BA-48E4-B0B4-143E5ECF75DCQ43537012-A0F2468F-D173-40C4-A9D2-3033D9FD38B3Q44323391-3FE3A706-A554-4FFF-ABDA-8AD49F53783DQ47125015-B07CF3A8-45CC-4547-9970-6CD4033849E6Q47346343-D2B902A0-1EC2-400A-A5D3-009FF4DA3259Q47778919-A52A58CB-BD0B-4A38-8EF6-D6AEB0F37D31Q48627805-3C8BFE2D-3819-4DF3-BA28-E796228EEE35Q51136992-838C8CC1-7D46-4811-A3B5-0A2C4A7FF705Q52715754-D13BA4B4-2E96-449A-B015-499693526130Q52806184-069911FB-0E6C-4627-85CF-5917DA6F9838
P2860
Tumor recurrence after complete resection for non-small cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tumor recurrence after complete resection for non-small cell lung cancer.
@ast
Tumor recurrence after complete resection for non-small cell lung cancer.
@en
type
label
Tumor recurrence after complete resection for non-small cell lung cancer.
@ast
Tumor recurrence after complete resection for non-small cell lung cancer.
@en
prefLabel
Tumor recurrence after complete resection for non-small cell lung cancer.
@ast
Tumor recurrence after complete resection for non-small cell lung cancer.
@en
P2093
P1476
Tumor recurrence after complete resection for non-small cell lung cancer.
@en
P2093
Alykhan S Nagji
Benjamin D Kozower
Christine L Lau
David R Jones
Matthew D Taylor
Nicholas Theodosakis
P304
1813-20; discussion 1820-1
P356
10.1016/J.ATHORACSUR.2012.03.031
P407
P577
2012-04-26T00:00:00Z